Anti-Atherosclerotic Effects of Pioglitazon by Interference with Inflammatory and Stress Pathway in Male Rabbits
Anti-Atherosclerotic Effects of Pioglitazon by Interference with Inflammatory and Stress Pathway in Male Rabbits

Hajar Nazar Hashem; Fadhil A. Rizij

Volume 6, Issue 4 , April 2023, , Pages 746-754

https://doi.org/10.26655/JMCHEMSCI.2023.4.5

Abstract
  Atherosclerosis is the leading cause of death worldwide. It is now widely accepted that it is a chronic inflammatory process. Minor inflammation, increased oxidative stress, and lipid ...  Read More
Evaluation of Anti-atherosclerotic Effects of Melatonin Interference with Inflammatory and Oxidative Stress Pathway in Male Rabbits
Evaluation of Anti-atherosclerotic Effects of Melatonin Interference with Inflammatory and Oxidative Stress Pathway in Male Rabbits

Hajar Nazar Hashem; Fadhil A. Rizij

Volume 6, Issue 3 , March 2023, , Pages 559-568

https://doi.org/10.26655/JMCHEMSCI.2023.3.13

Abstract
  Atherosclerosis is the primary cause of death worldwide. It is now commonly acknowledged that it is a persistent inflammatory process. Minor inflammation, increased oxidative stress, ...  Read More
Role of Kaempferol Combined with Pioglitazone in the Alleviation of Inflammation and Modulation of Necroptosis and Apoptosis Pathways in NASH-induced Mice
Role of Kaempferol Combined with Pioglitazone in the Alleviation of Inflammation and Modulation of Necroptosis and Apoptosis Pathways in NASH-induced Mice

Asmaa R. Abdel-Hamed; Amir O. Hamouda; Dina M. Abo-elmatty; Naglaa F. Khedr; Maivel H. Ghattas

Volume 6, Issue 2 , February 2023, , Pages 250-268

https://doi.org/10.26655/JMCHEMSCI.2023.2.8

Abstract
  Background: Nonalcoholic steatohepatitis (NASH) is one of the most serious health problems in the world. Apoptosis and necroptosis signaling pathways are highly implicated in NASH. ...  Read More
Study of heterocyclic-fused pyridazinone analogues having phosphodiestrase-IV inhibitor activities as anti-inflammatory agents
Study of heterocyclic-fused pyridazinone analogues having phosphodiestrase-IV inhibitor activities as anti-inflammatory agents

Mohammad Asif; . Abida; Md. Tauquir Alam

Volume 3, Issue 2 , April 2020, , Pages 109-117

https://doi.org/10.26655/jmchemsci.2020.2.3

Abstract
  Phosphodiesterase-IV (PDE- IV) inhibitors which are effective anti-inflammatory agents have forced researchers to find new PDE-IV inhibitors with less adverse effects than conventional ...  Read More